Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 9 Cancer Pain 5 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Agnosia 3 Rectal Neoplasms 2 Chronic Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Prostatic Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Pleural Effusion, Malignant 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Ileus 1 Failed Back Surgery Syndrome 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Arrhythmias, Cardiac 1

Interventions

Midazolam 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminal Cancer × Fentanyl × Clear all

NCT02009306 2018-05-09

Nasal Fentanyl and Buccal Midazolam for Dying Patients

Gloucestershire Hospitals NHS Foundation Trust

Phase 4 Completed

Terminal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡